Liabilities / Assets
54th percentile
Tied with the lowest-debt nonprofits in its peer group.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
54th percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
54th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
67th percentile
Higher net margin than 67% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
85th percentile
Faster asset growth than 85% of similar nonprofits.
Revenue Growth
58th percentile
Faster revenue growth than 58% of similar nonprofits.
Assets
Up$53,926
Up $18,204 (+51%) from 2016
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
$0
No earlier filing loaded for comparison.
Revenue
Up$147,311
Up $8,175 (+5.9%) from 2016
Expenses
Down$129,107
Down $52,840 (-29%) from 2016
Net Income
Up$18,204
Up $61,015 (+143%) from 2016
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Cure first mission is to accelerate discovery of targeted and less toxic treatment for cancer using innovative technologies.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990EZSummary only. Only limited summary data is available for this year.